Advertisements



Novartis (NVS) Announces Positive Data on Heart Failure Drug

Novartis AG.....»»

Category: topSource: zacksMar 20th, 2017

Novartis (NVS) Announces Positive Data on Heart Failure Drug

Novartis AG.....»»

Category: topSource: zacksMar 20th, 2017

Novartis (NVS) Presents Positive Data on Cardiovascular Drug

Novartis (NVS) presented new analysis from the PARADIGM-HF study on Entresto at a scientific meeting of the Heart Failure Society of America. Novartis AG NVS announces new analysis from the PARADIGM-HF study on its cardiovascular drug, Entresto.....»»

Category: topSource: zacksSep 19th, 2016

Novartis Offers Positive Data on Cardiovascular Drug Entresto

Novartis (NVS) announces new analysis from the PARADIGM-HF study on Entresto at a scientific session of the American Heart Association. Novartis AG NVS announced new analysis of the PARADIGM-HF study on its cardiovascular drug, Entresto, at a s.....»»

Category: topSource: zacksNov 16th, 2016

Novartis Announces Positive Data on Urticaria Drug Xolair

Novartis AG (NVS) announced new positive data on chronic spontaneous urticaria (CSU) drug Xolair from a phase IIIb study, OPTIMA. .....»»

Category: smallbizSource: nytSep 18th, 2017

Novartis Announces Positive Data on Cardiovascular Drug

Novartis AG (NVS) announced positive primary data on pipeline candidate canakinumab (ACZ885). Novartis AG NVS a.....»»

Category: personnelSource: nytAug 28th, 2017

Roche (RHHBY) Announces Positive Data on Leukemia Drug

Zacks.....»»

Category: topSource: redinewsSep 19th, 2017

Roche (RHHBY) Announces Positive Data on Leukemia Drug

Roche Holdings AG (RHHBY) announced positive results from the phase III study, MURANO on leukemia drug Venclexta. Roche Holdings AG RHHBY announced positive results from the phase III study, MURANO.The study evaluated Vencle.....»»

Category: personnelSource: nytSep 19th, 2017

Novartis Announces Long-Term Data on Psoriasis Drug Cosentyx

Novartis' (NVS) Cosentyx showed robust skin clearance data over a period of five years in patients with moderate-to-severe plaque psoriasis. Novartis AG NVS announced long-last.....»»

Category: smallbizSource: nytSep 14th, 2017

Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod

All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval. This week’s highlights include positive .....»»

Category: topSource: zacksJun 23rd, 2017

Novartis Announces Positive Results for Cardiovascular Drug

Novartis AG (NVS) announced top-line results from the global phase III study, CANTOS on cardiovascu.....»»

Category: topSource: zacksJun 22nd, 2017

Novartis Announces Positive Results for Cardiovascular Drug

Novartis AG NVS announced positive to.....»»

Category: blogSource: benzingaJun 22nd, 2017

Regeneron stock surges 6% after Novartis releases positive data for rival drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 20th, 2017

Regeneron stock surges 7% after Novartis releases positive data for rival drug

Regeneron Pharmaceuticals Inc. shares surged 6.6% in midday trade Tuesday after Novartis AG released positive data for two late-stage trials comparing its ey.....»»

Category: topSource: marketwatchJun 20th, 2017

Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx

Novartis AG NVS announced positive data on arthritis drug Cosentyx from two phase III studies at the Annual European Congress of Rheumatology (EULAR 2017), in Madrid. read more.....»»

Category: blogSource: benzingaJun 15th, 2017

Novartis Presents Positive Data on CAR-T Cell Therapy Drug

Novartis AG NVS announced .....»»

Category: blogSource: benzingaJun 12th, 2017

Novartis Presents Positive Data on CAR-T Cell Therapy Drug

Novartis AG (NVS) announced data from an interim analysis from a phase II study on lymphoma candidate. Novartis AG NVS announced data from an interim analysis from its multi-center global phase II study, JULTIET (NCT02445248). The study e.....»»

Category: topSource: zacksJun 12th, 2017

Radius (RDUS) Announces Positive Data on Breast Cancer Drug

Radius .....»»

Category: topSource: zacksJun 5th, 2017

Novartis Reports Positive Data on Breast Cancer Drug Kisqali

Zacks.....»»

Category: topSource: redinewsJun 2nd, 2017

Novartis Reports Positive Data on Breast Cancer Drug Kisqali

Novartis AG (NVS) announced positive.....»»

Category: topSource: zacksJun 2nd, 2017

Novartis Profit Dented by Investment in New Drugs

Novartis said profit fell in the first quarter as it pumped investment into the launch of its new heart-failure drug Entresto that it hopes will help offset revenue lost as best-selling cancer medicine Gleevec loses out to cheaper competitors......»»

Category: smallbizSource: wsjApr 25th, 2017